ClinicalTrials.gg
RecruitingNCT07413887STIMEUpdated Jun 1, 2026

The STIME Project: Intersectoral Prevention of Severe Youth Mental Health Difficulties

An interventional study of 'Signs of Disordered Eating' and 'Signs of Self-Harm' in Preventive Intervention and Mental Health Difficulties, sponsored by Center for Clinical Research and Prevention. Recruiting at 1 site in Denmark. Open to participants aged 3 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Center for Clinical Research and Prevention · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,200
Allocation
Randomized
Ages
3 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Psychological Well-Being with a site in Denmark — 9 open to participants now, 11 under way, none of them phase 3. Psychological Well-Being · Denmark.

Planned enrollment
5th of 29
1,200 · median 240
Started
2025
with 3 others
No phase
27 of 34
8 open now
Primary completion
2028-02
later than 10 of 10 live
Registered
30th of 34
by date
Lead sponsor
2 of 34
Center for Clinical Research and Prevention

Among the 34 studies in Psychological Well-Being with a site in Denmark, this one is the 5th largest by planned enrollment of the 29 interventional ones that give a count, is one of 4 that started in 2025, is one of 27 with no phase, reaches primary completion later than 10 of the 10 other live ones, and was the 30th registered.

Psychological Well-Being

2,208 studies on the registry are indexed under Psychological Well-Being; 730 are open to participants now.

Browse Psychological Well-Being studies →

Open to participants now

9 of the 34 studies in Psychological Well-Being with a site in Denmark are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 403 Psychological Well-Being studies recruiting now, 223 (55%) set no upper age limit and 155 (38%) stop at 75 or younger; 121 take children under 18; 206 take healthy volunteers.

This study: 3 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Psychological Well-Being with a site in Denmark, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effectiveness of participation in five different STIME (Strengthened Cross-Sectoral Initiative for Children and Young People's Mental Health) interventions: 'Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Self-Harm', 'Take the Control Back', and 'The Parent Pilots'. The hypothesis is that participation in one of these interventions will be more effective than Management As Usual (MAU). Each intervention consists of three core components: early identification and screening, therapy based on evidence-informed manuals, and support within the child's learning environment.

Read the detailed description

This project consists of five separate randomized controlled trials, each designed to evaluate the effectiveness of one of the five STIME interventions.

Mental health difficulties in childhood can have wide-ranging negative consequences for a child's development, learning, education, physical and psychological health in adulthood, family formation, and later attachment to the labor market. Thus, mental health difficulties among children and adolescents constitute a significant public health issue that requires immediate cross-sectoral action.

Existing research points to effective strategies for the prevention of progression of mental health difficulties to mental health problems that require psychiatric treatment. However, we still know relatively little about whether and how interventions work in the real-life contexts in which they are intended to function. In particular, there is a lack of research on implementation in practice-an evidence gap that may be bridged by integrating systematic evaluation components into existing prevention programs such as STIME.

STIME is a collaboration between municipalities and the regional child and adolescent psychiatry, aiming to prevent the progression of mental health difficulties among children and adolescents aged 3-17 years, before specialized treatment is required. The interventions target a subclinical population-that is, children and adolescents who show signs of mental health difficulties, such as anxiety, disordered eating, or self-harm, but who do not meet the diagnostic criterias for a mental disorder. As part of the collaboration, regional mental health services are responsible for training municipal psychologists, while the municipalities are in charge of delivering the interventions.

Although a pilot evaluation indicates that the STIME interventions are promising, there is a need for a rigorous examination of their effectiveness. The present study will therefore investigate the effectiveness of five STIME interventions.

The study will be conducted as five separate randomized controlled trials. Participants eligible for partaking in 'Signs of Disordered Eating' will be allocated either to the intervention or MAU, involving a maximum of four online 45 min sessions over a period of ten weeks with a psychologist, upon which the 'Signs of Disordered Eating' intervention will be offered. Participants eligible for participation in 'Signs of Self-harm', 'Signs of Internalizing' or 'Take the Control Back' will be allocated either to the intervention or MAU, involving a maximum of three online 45 min sessions over a period of ten weeks with a psychologist, upon which the relevant intervention will be offered. The control group psychologists will have previous experience with the appropriate populations, but no prior knowledge or training in the STIME concepts.

For 'the Parent Pilots' intervention, parents will be randomized to either commencement of the intervention within the first group or the following group, which will commence when the first group finishes after ten weeks. As such, this will be a passive waitlist control group.

The primary aim is to determine whether participation in a STIME intervention results in greater improvements in mental health difficulties and everyday functioning compared to the control group. Effectiveness will be assessed using validated measures of wellbeing (primary outcome of interest) and functionality indicators relevant to each intervention's mental health difficulty (secondary outcome of interest). Outcomes will be measured at baseline (T0), immediately post intervention (T1), and six months post baseline (T2).

03

Conditions studied

  • Preventive Intervention
  • Mental Health Difficulties

Keywords

  • Mental Health
  • Adolescents
  • Children
  • Preventive intervention
  • Sub-clinical symptoms
  • Randomized controlled trial
04

Who can participate

Ages eligible
3 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Each of the interventions has elaborate and narrowly defined inclusion and exclusion criteria. These are listed below for each intervention.

'Signs of Internalizing'

Inclusion criteria

  • Adolescents aged 12-17 years
  • Mild to moderate impairment in daily functioning (e.g., reduced engagement in school, social life, or leisure activities compared to before symptoms)
  • Adolescents with well-managed ADHD or autism may be included if they demonstrate sufficient mentalizing abilities and can benefit from the intervention with parental support
  • Presence of both anxiety and depressive symptoms, neither of which dominates or meets full diagnostic criteria
  • The family is motivated to participate

Exclusion criteria

  • Symptoms of moderate to severe depression
  • Presence of OCD, PTSD, agoraphobia, panic disorder, or other psychiatric conditions
  • Low cognitive functioning
  • Moderate to severe functional impairment (e.g., school dropout, extreme social withdrawal, daily reliance on adult support, lack of motivation for treatment)
  • Recent unsuccessful psychological treatment
  • Primary problems related to family dynamics or a highly burdened family situation
  • Increased or acute suicide risk
  • Presence of self-harm or symptoms of disordered eating

'Signs of Disordered Eating'

Inclusion criteria

  • Children and adolescents aged 10-17 years
  • High body dissatisfaction, preoccupation with food and/or body image, and/or early behavioral signs of an eating disorder
  • Stable physical condition, manageable in consultation with the adolescent's general practitioner
  • Able to consume food with guidance and support
  • The family is motivated to participate

Exclusion criteria

  • Previous treatment for an eating disorder
  • Symptoms meeting criteria for specialized psychiatric treatment
  • Low cognitive functioning
  • Significant weight loss
  • Solely restrictive or selective eating without other eating disorder symptoms
  • Severe comorbidity
  • Increased or acute suicide risk
  • Eating difficulties solely related to lifestyle factors

'Signs of Self-Harm'

Inclusion criteria

  • Adolescents aged 12-17 years
  • Current thoughts of self-harm
  • At least one episode of direct (non-suicidal) self-harm within the past three months
  • The family is motivated to participate

Exclusion criteria

  • Increased suicide risk
  • Psychiatric disorder requiring further assessment or not adequately treated
  • Low cognitive functioning
  • Self-harm only in socially accepted contexts (e.g., piercings or tattoos)
  • Only indirect self-harm (e.g., excessive substance use)
  • Only self-harm by proxy (involving another person)

'Take the Control Back'

Inclusion criteria

  • Children and adolescents aged 5-17 years
  • Experiencing obsessive thoughts and/or compulsive behaviors of mild to moderate severity
  • Experiencing self-perceived distress related to obsessive thoughts and/or compulsive behaviors
  • Experiencing obsessive thoughts as egodystonic, and thus aware that they are excessive (for the youngest participants, this criterion may be waived in cases of limited insight)
  • Functioning is impaired by obsessive thoughts and/or behaviors, e.g., reduced school functioning, social difficulties, or impaired functioning at home
  • The family is motivated to participate

Exclusion criteria

  • Symptoms meeting criteria for specialized psychiatric treatment
  • Has another psychiatric disorder that requires assessment or is not adequately managed
  • Has difficulties other than obsessive thoughts and behaviors that currently constitute the primary burden, and which must be addressed first
  • Has previously received OCD treatment within psychiatric care (may be offered STIME if assessed but not treated due to mild severity)
  • Has an increased or acute risk of suicide
  • Has low functioning for other reasons, e.g., significantly reduced cognitive functioning

'the Parent Pilots'

Inclusion criteria

  • Parents of children aged 3-10 years who experience developmentally inappropriate difficulties with restlessness, hyperactivity, attention, and/or impulsivity
  • The symptoms must be present at home as a minimum, but may also occur across settings such as home, daycare, and school
  • The child's difficulties must be significant enough to affect overall daily functioning
  • The parents are motivated to participate

Exclusion Criteria:

  • Symptoms of attention difficulties that require psychiatric treatment
  • Presence of another psychiatric disorder that requires treatment
  • Previous treatment for ADHD within the psychiatric system
  • Low level of functioning due to other causes, such as significantly reduced cognitive functioning
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
1,200 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Behavioral: 'Signs of Disordered Eating' · Behavioral: 'Signs of Self-Harm' · Behavioral: 'Signs of Internalizing' · Behavioral: 'the Parent Pilots' · Behavioral: 'Take the Control Back'

  • Active comparator
    Control group

    Behavioral: Active comparator ('Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Self-harm' and 'Take the Control Back')

  • No intervention
    Passive Control ('the Parent Pilots')

    For the STIME intervention, 'the Parent Pilots', half of the families will be randomly assigned to the control group and will be enrolled in the intervention after 10 weeks.

Interventions

  • Behavioral'Signs of Disordered Eating'

    A manual-based family intervention for children and adolescents (10-17 years) experiencing overwhelming thoughts about food and body image, without meeting criteria for a diagnosed eating disorder. The intervention spans 2-3 months and consists of 5-10 sessions. A STIME therapist from the child's local municipality conducts the sessions with either the parents alone (for children aged 10-12 years) or with the whole family (for children aged 13-17 years). The intervention is based on family-based therapy, emphasizing the parents' role in supporting their child's healthy development. The intervention focuses on presentation of difficulties and change, incorporating elements from Cognitive Behavioral Therapy (CBT), including externalization, validation, and skills training. Practical strategies are applied through homework assignments, goal setting, and self-monitoring.

  • Behavioral'Signs of Self-Harm'

    A manual-based intervention targeting adolescents (12-17 years) with self-harming thoughts and behaviors not requiring specialized psychiatric care. The intervention involves 9 sessions delivered by a trained STIME therapist, with both joint and individual sessions involving the adolescent and parents. Based on CBT, it integrates methods from Acceptance and Commitment Therapy (ACT), Dialectical Behavior Therapy (DBT), and Emotion-Focused Therapy (EFT). Focus areas include developing an understanding of the function and consequences of self-harm, as well as the role and impact of emotions in behavior.

  • Behavioral'Signs of Internalizing'

    A manual-based CBT intervention targeting adolescents (aged 12-17 years) with emotional difficulties consistent with anxiety and subclinical to mild depression, but not requiring treatment in specialized psychiatric care. The intervention begins with an assessment session and includes up to 14 sessions across 9 modules (6 core, 3 optional). Based on CBT, the intervention seeks to enhance the adolescent's understanding of how emotional experiences influence cognitive processes, physiological responses, and behavior. Methods include behavioral experiments, exposure, and emotion regulation strategies. The therapy is grounded in an individual case formulation, which identifies the maintaining factors of the young person's emotional difficulties and sets concrete goals for therapeutic work and change. Sessions involve the adolescent, parents, and relevant network members. Homework is assigned between sessions to support daily-life implementation.

  • Behavioral'the Parent Pilots'

    A manual-based intervention for children and adolescents with subclinical signs of Attention Deficit Hyperactivity Disorder (ADHD). The intervention consists of four group sessions during 6-8 weeks, including parents/caregivers of up to eight children/adolescents, and is conducted by a STIME therapist from the child's local municipality. Individual sessions can be added when considered beneficial based on the family's needs. The intervention is based on family-based therapy and Vygotsky's Zone of Proximal Development and focuses on empowering parents to understand and address their child's behaviors. Between sessions, parents complete manual-structured homework and real-life practice at home. To reinforce progress and ensure consistency across the home and education settings, professionals from the child's educational setting or broader support network may also be involved

  • Behavioral'Take the Control Back'

    A manual-based intervention for children and adolescents (aged 5-17 years) with mild to moderate obsessive thoughts and compulsive behaviors, but not requiring treatment in specialized psychiatric care. The intervention begins with an assessment session and includes a minimum of eight sessions. Grounded in family-based cognitive behavioral therapy, it combines goal-focused work, psychoeducation, exposure, response, and prevention as the main therapeutic components. The primary aim is to support the child/adolescent in being exposed to situations that may trigger obsessive thoughts and to refrain from allowing these thoughts to dictate behavior. Sessions involve the child/adolescent and their parents. To support the process, it is possible to involve professionals from the learning environment and the child/adolescent's wider network. Homework assignments are given between sessions for both the child/adolescent and their parents, to support practice in daily life.

  • BehavioralActive comparator ('Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Self-harm' and 'Take the Control Back')

    For the STIME-interventions 'Signs of Disordered Eating', 'Signs of Internalizing', 'Signs of Self-harm', and 'Take the control back', children and adolescents allocated to the control group will receive 3-4 individual online sessions with a psychologist over 10 weeks while waiting to start the intervention. The number of sessions depends on the presenting concern: up to three sessions for the interventions 'Signs of Internalizing', 'Signs of Self-harm', and 'Take the control back', and up to four sessions for the intervention 'Signs of Disordered Eating'. Sessions may involve the child/adolescent alone, the parents alone, or both together. Psychologists providing the sessions have experience working with all target groups, but have not received training in the STIME program. They will be given freedom to use less than the maximum number of sessions and to choose their therapeutic approach to mimic the variability of management as usual.

06

What researchers measure

Primary outcomes

  1. Well-being

    WHO-5 Well-being Index (Topp et al., 2015). The World Health Organization Five Well-Being Index, minimum score of 0 and maximum score 25, where higher scores indicate better mental well-being.

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

Secondary outcomes

  1. Disordered Eating

    The study will assess signs of disordered eating among participants enrolled in the STIME intervention 'Signs of Disordered Eating', using the Eating Attitudes Test (EAT-26) (Garfinkel \& Newman, 2001; Garner et al., 1982). The Eating Attitudes Test-26 (EAT-26) is the Eating Attitudes Test, 26-item version, a self-report screening measure for disordered eating attitudes and behaviors with a total score that can range from 0 to 78, where higher scores indicate greater eating-related concern and risk.

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

  2. Emotional dysregulation

    The study will assess emotional dysregulation among participants enrolled in the STIME intervention 'Signs of Self-harm', using the Difficulties in Emotion Regulation Scale (DERS-16) (Gratz \& Roemer, 2004). The Difficulties in Emotion Regulation Scale - 16-item version (DERS-16) is a brief self-report measure of overall difficulties in emotion regulation with 16 items rated on a 5-point scale yielding a total score that ranges from 16 to 80, where higher scores indicate greater difficulties in emotion regulation.

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

  3. Anxiety and depression

    The study will assess signs of anxiety and depression among participants enrolled in the STIME intervention, 'Signs of Internalizing', using the Revised Child Anxiety and Depression Scale (RCADS) (Esbjørn et al., 2012). The Revised Child Anxiety and Depression Scale (RCADS) is the Revised Child Anxiety and Depression Scale self-report questionnaire (usually 47 items) that assesses DSM-defined anxiety and depression symptoms with item scores from 0 ("Never") to 3 ("Always"), yielding subscale and total raw scores that can range from 0 (no symptoms) up to the maximum possible summed raw score (e.g., 0-141 for the full 47-item version) where higher scores indicate greater anxiety and/or depressive symptom severity.

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

  4. Impulsivity, hyperactivity, and inattention difficulties

    The study will assess signs of impulsivity, hyperactivity, and inattention difficulties among participants enrolled in the STIME intervention, 'The Parent Pilots', using the Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS) (Szomlaiski et al., 2009). The Attention-Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS) is the ADHD Rating Scale (often aligned with DSM criteria in its current ADHD-RS-5/IV versions) consisting of 18 items scored from 0 ("never/rarely") to 3 ("very often") with a total raw score range of 0 to 54, where higher scores indicate greater severity of ADHD symptoms

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

  5. Obsessive thoughts and compulsive behaviors

    The study will assess signs of obsessive thoughts and compulsive behaviours among participants enrolled in the STIME intervention 'Take the control back', using an adapted and translated version of the Yale-Brown Obsessive Compulsive Scale (Goodman WK et al., 1989) (currently undergoing validation in a Danish youth population).

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

  6. Well-being SDQ

    SDQ Impact Scale (Goodman, A. \& Goodman, R., 2009). Strengths and Difficulties Questionnaire (SDQ) Impact Scale supplemental to the SDQ is the SDQ Impact Supplement assessing overall distress and impairment, with an impact score that ranges from 0 to 10 for parent- and self-report (and 0 to 6 for teacher report), where higher scores indicate greater impact of difficulties on the child's life

    Time frame: For intervention group: From enrollment (T0) to the end of treatment (10 weeks) (T1) and 6 months post T0. For control group: From enrollment (T0) to 10 weeks (T1).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. Journal of Psychopathology and Behavioral Assessment. 2004;26:41-54.
  • Goodman A, Goodman R. Strengths and difficulties questionnaire as a dimensional measure of child mental health. J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):400-403. doi: 10.1097/CHI.0b013e3181985068. PubMed 19242383 ↗
  • Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov;46(11):1006-11. doi: 10.1001/archpsyc.1989.01810110048007. PubMed 2684084 ↗
  • Szomlaiski N, Dyrborg J, Rasmussen H, Schumann T, Koch SV, Bilenberg N. Validity and clinical feasibility of the ADHD rating scale (ADHD-RS) A Danish Nationwide Multicenter Study. Acta Paediatr. 2009 Feb;98(2):397-402. doi: 10.1111/j.1651-2227.2008.01025.x. Epub 2008 Sep 4. PubMed 18775056 ↗
  • Esbjorn BH, Somhovd MJ, Turnstedt C, Reinholdt-Dunne ML. Assessing the Revised Child Anxiety and Depression Scale (RCADS) in a national sample of Danish youth aged 8-16 years. PLoS One. 2012;7(5):e37339. doi: 10.1371/journal.pone.0037339. Epub 2012 May 23. PubMed 22649520 ↗
  • Garfinkel PE, Newman A. The eating attitudes test: twenty-five years later. Eat Weight Disord. 2001 Mar;6(1):1-24. doi: 10.1007/BF03339747. PubMed 11300541 ↗
  • Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: psychometric features and clinical correlates. Psychol Med. 1982 Nov;12(4):871-8. doi: 10.1017/s0033291700049163. PubMed 6961471 ↗
  • Topp CW, Ostergaard SD, Sondergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167-76. doi: 10.1159/000376585. Epub 2015 Mar 28. PubMed 25831962 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Feb 2028, 26 months after the start.

Of 1,274 non-industry interventional studies with no phase under Psychological Well-Being, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 34. This study's planned 26 months is above that.

Counting every sponsor, half of 1,317 studies reached it within 16 months; a quarter within 7 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2026
First posted
Feb 17, 2026
StartActual
Nov 20, 2025
Primary completionEst.
Feb 1, 2028
CompletionEst.
Feb 1, 2028
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07413887
Lead sponsor
Center for Clinical Research and Prevention
Responsible party
Sponsor
First posted
Feb 17, 2026
Start date
Nov 20, 2025
Primary completion
Feb 1, 2028 (estimated)
Completion
Feb 1, 2028 (estimated)
Last update
Jun 1, 2026

Study contacts

Michaela Louise Schiøtz, PhD, cand.scient.san.publ.
Contact
michaela.louise.schioetz@regionh.dk
+4527333083
Thea T Amholt, PhD, cand.psych
Contact
thea.toft.amholt@regionh.dk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion